Researchers develop treatment for rare, genetic liver disease
Researchers at Saint Louis University’s School of Medicine, in collaboration with Arrowhead Pharmaceuticals and Takeda Pharmaceuticals, report the first effective drug to treat a rare, genetic liver disease that formerly could only be treated with a liver transplant. The study, “Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency,” was published online in the New England […]
Continue Reading